175 related articles for article (PubMed ID: 32059452)
1. Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.
Horio T; Morishita E; Mizuno S; Uchino K; Hanamura I; Espinoza JL; Morishima Y; Kodera Y; Onizuka M; Kashiwase K; Fukuda T; Doki N; Miyamura K; Mori T; Nakao S; Takami A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32059452
[TBL] [Abstract][Full Text] [Related]
2. Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.
Uchino K; Vu Quang L; Mizuno S; Horio T; Yamamoto H; Hanamura I; Kodera Y; Luis Espinoza J; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Doki N; Miyamura K; Mori T; Morishita E; Nakao S; Takami A
Genes Immun; 2021 May; 22(1):35-43. PubMed ID: 33627833
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1 gene rs2071746 polymorphism in retinal vein occlusion.
Posch-Pertl L; List W; Michelitsch M; Pinter-Hausberger S; Berisha B; Posch F; Kloeckl L; Renner W; Weger M
Ophthalmic Genet; 2022 Oct; 43(5):627-632. PubMed ID: 35762119
[TBL] [Abstract][Full Text] [Related]
4. Association between the heme oxygenase-1 promoter polymorphism and renal transplantation outcome in Greece.
Katana E; Skoura L; Giakoustidis D; Takoudas D; Malisiovas N; Daniilidis M
Transplant Proc; 2010 Sep; 42(7):2479-85. PubMed ID: 20832528
[TBL] [Abstract][Full Text] [Related]
5. Donor heme oxygenase-1 genotype is associated with renal allograft function.
Exner M; Böhmig GA; Schillinger M; Regele H; Watschinger B; Hörl WH; Raith M; Mannhalter C; Wagner OF
Transplantation; 2004 Feb; 77(4):538-42. PubMed ID: 15084931
[TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1 genotype of the donor is associated with graft survival after liver transplantation.
Buis CI; van der Steege G; Visser DS; Nolte IM; Hepkema BG; Nijsten M; Slooff MJ; Porte RJ
Am J Transplant; 2008 Feb; 8(2):377-85. PubMed ID: 18093274
[TBL] [Abstract][Full Text] [Related]
7. (GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation.
Køllgaard T; Kornblit B; Petersen J; Klausen TW; Mortensen BK; Brændstrup P; Sengeløv H; Høgdall E; Müller K; Vindeløv L; Andersen MH; Thor Straten P
PLoS One; 2016; 11(12):e0168210. PubMed ID: 27997582
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.
Gill AJ; Garza R; Ambegaokar SS; Gelman BB; Kolson DL
J Neuroinflammation; 2018 Mar; 15(1):70. PubMed ID: 29510721
[TBL] [Abstract][Full Text] [Related]
9. A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
Nomoto H; Takami A; Espinoza JL; Matsuo K; Mizuno S; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Ohtake S; Morishita E
Int J Hematol; 2015 Oct; 102(4):460-70. PubMed ID: 26246110
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor genetic variations in bone marrow transplantation.
Uchino K; Mizuno S; Sato-Otsubo A; Nannya Y; Mizutani M; Horio T; Hanamura I; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Ogawa S; Takami A
Oncotarget; 2017 Jul; 8(28):45670-45686. PubMed ID: 28484092
[TBL] [Abstract][Full Text] [Related]
11. Recipient
Nomoto H; Takami A; Espinoza JL; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori T; Nakao S; Morishita E
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626079
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase-1 promoter polymorphisms and risk of spina bifida.
Fujioka K; Yang W; Wallenstein MB; Zhao H; Wong RJ; Stevenson DK; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):741-6. PubMed ID: 26173399
[TBL] [Abstract][Full Text] [Related]
13. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
14. The Heme Oxygenase System in Hematological Malignancies.
Li Volti G; Tibullo D; Vanella L; Giallongo C; Di Raimondo F; Forte S; Di Rosa M; Signorelli SS; Barbagallo I
Antioxid Redox Signal; 2017 Aug; 27(6):363-377. PubMed ID: 28257621
[TBL] [Abstract][Full Text] [Related]
15. Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies.
Espinoza JL; Takami A; Onizuka M; Morishima Y; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Biol Blood Marrow Transplant; 2013 Feb; 19(2):240-6. PubMed ID: 23025987
[TBL] [Abstract][Full Text] [Related]
16. The role of heme oxygenase-1 in pulmonary disease.
Fredenburgh LE; Perrella MA; Mitsialis SA
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):158-65. PubMed ID: 16980551
[TBL] [Abstract][Full Text] [Related]
17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
20. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
Davies SM; DeFor TE; McGlave PB; Miller JS; Verfaillie CM; Wagner JE; Weisdorf DJ
Am J Med; 2001 Apr; 110(5):339-46. PubMed ID: 11286947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
